Dying for a cause: invertebrate genetics takes on human neurodegeneration
10.1038/nrg1018
Crossref journal-article
Springer Science and Business Media LLC
Nature Reviews Genetics (297)
Bibliography

Driscoll, M., & Gerstbrein, B. (2003). Dying for a cause: invertebrate genetics takes on human neurodegeneration. Nature Reviews Genetics, 4(3), 181–194.

Authors 2
  1. Monica Driscoll (first)
  2. Beate Gerstbrein (additional)
References 136 Referenced 121
  1. Baumeister, R. & Ge, L. The worm in us: Caenorhabditis elegans as a model of human disease. Trends Biotechnol. 20, 147–148 (2002). (10.1016/S0167-7799(01)01925-4) / Trends Biotechnol. by R Baumeister (2002)
  2. Bernards, A. & Hariharan, I. K. Of flies and men — studying human disease in Drosophila. Curr. Opin. Genet. Dev. 11, 274–278 (2001). (10.1016/S0959-437X(00)00190-8) / Curr. Opin. Genet. Dev. by A Bernards (2001)
  3. Bargmann, C. I. Neurobiology of the Caenorhabditis elegans genome. Science 282, 2028–2033 (1998). (10.1126/science.282.5396.2028) / Science by CI Bargmann (1998)
  4. Yoshihara, M., Ensminger, A. W. & Littleton, J. T. Neurobiology and the Drosophila genome. Funct. Integr. Genomics 1, 235–240 (2001). (10.1007/s101420000029) / Funct. Integr. Genomics by M Yoshihara (2001)
  5. Liu, Q. A. & Hengartner, M. O. The molecular mechanism of programmed cell death in C. elegans. Ann. N Y Acad. Sci. 887, 92–104 (1999). (10.1111/j.1749-6632.1999.tb07925.x) / Ann. N Y Acad. Sci. by QA Liu (1999)
  6. Richardson, H. & Kumar, S. Death to flies: Drosophila as a model system to study programmed cell death. J. Immunol. Methods 265, 21–38 (2002). (10.1016/S0022-1759(02)00068-6) / J. Immunol. Methods by H Richardson (2002)
  7. Lee, J. M., Grabb, M. C., Zipfel, G. J. & Choi, D. W. Brain tissue responses to ischemia. J. Clin. Invest. 106, 723–731 (2000). (10.1172/JCI11003) / J. Clin. Invest. by JM Lee (2000)
  8. Haddad, G. G., Sun, Y., Wyman, R. J. & Xu, T. Genetic basis of tolerance to O2 deprivation in Drosophila melanogaster. Proc. Natl Acad. Sci. USA 94, 10809–10812 (1997). (10.1073/pnas.94.20.10809) / Proc. Natl Acad. Sci. USA by GG Haddad (1997)
  9. Ma, E., Gu, X. Q., Wu, X., Xu, T. & Haddad, G. G. Mutation in pre-mRNA adenosine deaminase markedly attenuates neuronal tolerance to O2 deprivation in Drosophila melanogaster. J. Clin. Invest. 107, 685–693 (2001). (10.1172/JCI11625) / J. Clin. Invest. by E Ma (2001)
  10. Palladino, M. J., Keegan, L. P., O'Connell, M. A. & Reenan, R. A. A-to-I pre-mRNA editing in Drosophila is primarily involved in adult nervous system function and integrity. Cell 102, 437–449 (2000). (10.1016/S0092-8674(00)00049-0) / Cell by MJ Palladino (2000)
  11. Scott, B. A., Avidan, M. S. & Crowder, C. M. Regulation of hypoxic death in C. elegans by the insulin/IGF receptor homolog DAF-2. Science 296, 2388–2391 (2002). A genetic screen for hypoxia-resistance genes that identified roles for specific alleles of insulin-like receptor DAF-2 and some other components of the C. elegans insulin-like signalling pathway that are involved in hypoxia responses. (10.1126/science.1072302) / Science by BA Scott (2002)
  12. Gagliardi, R. J. Neuroprotection, excitotoxicity and NMDA antagonists. Arq. Neuropsiquiatr. 58, 583–588 (2000). (10.1590/S0004-282X2000000300030) / Arq. Neuropsiquiatr. by RJ Gagliardi (2000)
  13. Rossi, D. J., Oshima, T. & Attwell, D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403, 316–321 (2000). (10.1038/35002090) / Nature by DJ Rossi (2000)
  14. Sattler, R. & Tymianski, M. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol. Neurobiol. 24, 107–129 (2001). (10.1385/MN:24:1-3:107) / Mol. Neurobiol. by R Sattler (2001)
  15. Heintz, N. & Zoghbi, H. Y. Insights from mouse models into the molecular basis of neurodegeneration. Annu. Rev. Physiol. 62, 779–802 (2000). (10.1146/annurev.physiol.62.1.779) / Annu. Rev. Physiol. by N Heintz (2000)
  16. Yoon, J. et al. Novel mechanism of massive photoreceptor degeneration caused by mutations in the trp gene of Drosophila. J. Neurosci. 20, 649–659 (2000). (10.1523/JNEUROSCI.20-02-00649.2000) / J. Neurosci. by J Yoon (2000)
  17. Treinin, M. & Chalfie, M. A mutated acetylcholine receptor subunit causes neuronal degeneration in C. elegans. Neuron 14, 871–877 (1995). (10.1016/0896-6273(95)90231-7) / Neuron by M Treinin (1995)
  18. Treinin, M., Gillo, B., Liebman, L. & Chalfie, M. Two functionally dependent acetylcholine subunits are encoded in a single Caenorhabditis elegans operon. Proc. Natl Acad. Sci. USA 95, 15492–15495 (1998). (10.1073/pnas.95.26.15492) / Proc. Natl Acad. Sci. USA by M Treinin (1998)
  19. Yassin, L. et al. Characterization of the deg-3/des-2 receptor: a nicotinic acetylcholine receptor that mutates to cause neuronal degeneration. Mol. Cell. Neurosci. 17, 589–599 (2001). (10.1006/mcne.2000.0944) / Mol. Cell. Neurosci. by L Yassin (2001)
  20. Royal, D. & Driscoll, M. in Cell Death and Diseases of the Nervous System (eds Koliatsos, V. E. & Ratan, R. R.) 123–144 (Humana Press Inc., New Jersey, 1999). (10.1007/978-1-4612-1602-5_7) / Cell Death and Diseases of the Nervous System by D Royal (1999)
  21. Korswagen, H. C., Park, J. H., Ohshima, Y. & Plasterk, R. H. An activating mutation in a Caenorhabditis elegans Gs protein induces neural degeneration. Genes. Dev. 11, 1493–1503 (1997). (10.1101/gad.11.12.1493) / Genes. Dev. by HC Korswagen (1997)
  22. Berger, A. J., Hart, A. C. & Kaplan, J. M. Gαs-induced neurodegeneration in Caenorhabditis elegans. J. Neurosci. 18, 2871–2880 (1998). (10.1523/JNEUROSCI.18-08-02871.1998) / J. Neurosci. by AJ Berger (1998)
  23. Korswagen, H. C., van der Linden, A. M. & Plasterk, R. H. G protein hyperactivation of the Caenorhabditis elegans adenylyl cyclase SGS-1 induces neuronal degeneration. Embo J. 17, 5059–5065 (1998). (10.1093/emboj/17.17.5059) / Embo J. by HC Korswagen (1998)
  24. Driscoll, M. & Chalfie, M. The mec-4 gene is a member of a family of Caenorhabditis elegans genes that can mutate to induce neuronal degeneration. Nature 349, 588–593 (1991). (10.1038/349588a0) / Nature by M Driscoll (1991)
  25. Hong, K. & Driscoll, M. A transmembrane domain of the putative channel subunit MEC-4 influences mechanotransduction and neurodegeneration in C. elegans. Nature 367, 470–473 (1994). (10.1038/367470a0) / Nature by K Hong (1994)
  26. Adams, C. M., Snyder, P. M., Price, M. P. & Welsh, M. J. Protons activate brain Na+ channel 1 by inducing a conformational change that exposes a residue associated with neurodegeneration. J. Biol. Chem. 273, 30204–30207 (1998). (10.1074/jbc.273.46.30204) / J. Biol. Chem. by CM Adams (1998)
  27. Goodman, M. B. et al. MEC-2 regulates C. elegans DEG/ENaC channels needed for mechanosensation. Nature 415, 1039–1042 (2002). (10.1038/4151039a) / Nature by MB Goodman (2002)
  28. Hall, D. H. et al. Neuropathology of degenerative cell death in Caenorhabditis elegans. J. Neurosci. 17, 1033–1045 (1997). (10.1523/JNEUROSCI.17-03-01033.1997) / J. Neurosci. by DH Hall (1997)
  29. Schmitz, G. & Muller, G. Structure and function of lamellar bodies, lipid–protein complexes involved in storage and secretion of cellular lipids. J. Lipid Res. 32, 1539–1570 (1991). (10.1016/S0022-2275(20)41642-6) / J. Lipid Res. by G Schmitz (1991)
  30. Chung, S., Gumienny, T. L., Hengartner, M. O. & Driscoll, M. A common set of engulfment genes mediates removal of both apoptotic and necrotic cell corpses in C. elegans. Nature Cell Biol. 2, 931–937 (2000). (10.1038/35046585) / Nature Cell Biol. by S Chung (2000)
  31. Syntichaki, P., Xu, K., Driscoll, M. & Tavernarakis, N. Specific aspartyl and calpain proteases are required for neurodegeneration in C. elegans. Nature 419, 939–944 (2002). This work showed that, as in humans, Ca2+-activated proteases and cathepsin proteases are required for efficient progression through necrosis in C. elegans. (10.1038/nature01108) / Nature by P Syntichaki (2002)
  32. Xu, K., Tavernarakis, N. & Driscoll, M. Necrotic cell death in C. elegans requires the function of calreticulin and regulators of Ca2+ release from the endoplasmic reticulum. Neuron 31, 957–971 (2001). This work described identification of essential downstream components for ion channel-induced neurodegeneration in C. elegans and supported the theory that a rise in intracellular calcium is essential for necrotic cell death. (10.1016/S0896-6273(01)00432-9) / Neuron by K Xu (2001)
  33. Michalak, M., Corbett, E. F., Mesaeli, N., Nakamura, K. & Opas, M. Calreticulin: one protein, one gene, many functions. Biochem. J. 344, 281–292 (1999). (10.1042/bj3440281) / Biochem. J. by M Michalak (1999)
  34. Mattson, M. P. et al. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends. Neurosci. 23, 222–229 (2000). (10.1016/S0166-2236(00)01548-4) / Trends. Neurosci. by MP Mattson (2000)
  35. Chan, S. L. & Mattson, M. P. Caspase and calpain substrates: roles in synaptic plasticity and cell death. J. Neurosci. Res. 58, 167–190 (1999). (10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K) / J. Neurosci. Res. by SL Chan (1999)
  36. Yamashima, T. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog. Neurobiol. 62, 273–295 (2000). (10.1016/S0301-0082(00)00006-X) / Prog. Neurobiol. by T Yamashima (2000)
  37. Huang, Y. & Wang, K. K. The calpain family and human disease. Trends Mol. Med. 7, 355–362 (2001). (10.1016/S1471-4914(01)02049-4) / Trends Mol. Med. by Y Huang (2001)
  38. Yamashima, T. et al. Transient brain ischaemia provokes Ca2+, PIP2 and calpain responses prior to delayed neuronal death in monkeys. Eur. J. Neurosci. 8, 1932–1944 (1996). (10.1111/j.1460-9568.1996.tb01337.x) / Eur. J. Neurosci. by T Yamashima (1996)
  39. Heisenberg, M. & Böhl, K. Isolation of anatomical brain mutants of Drosophila by histological means. Z. Naturforsch 34, 143–147 (1979). (10.1515/znc-1979-1-228) / Z. Naturforsch by M Heisenberg (1979)
  40. Buchanan, R. L. & Benzer, S. Defective glia in the Drosophila brain degeneration mutant drop-dead. Neuron 10, 839–850 (1993). (10.1016/0896-6273(93)90200-B) / Neuron by RL Buchanan (1993)
  41. Kretzschmar, D., Hasan, G., Sharma, S., Heisenberg, M. & Benzer, S. The swiss cheese mutant causes glial hyperwrapping and brain degeneration in Drosophila. J. Neurosci. 17, 7425–7432 (1997). (10.1523/JNEUROSCI.17-19-07425.1997) / J. Neurosci. by D Kretzschmar (1997)
  42. Min, K. T. & Benzer, S. Spongecake and eggroll: two hereditary diseases in Drosophila resemble patterns of human brain degeneration. Curr. Biol. 7, 885–888 (1997). (10.1016/S0960-9822(06)00378-2) / Curr. Biol. by KT Min (1997)
  43. Min, K. T. & Benzer, S. Preventing neurodegeneration in the Drosophila mutant bubblegum. Science 284, 1985–1988 (1999). One of a series of papers that describe endogenous neurodegenerative mutations in the fly, in this case with notable resemblance to human adrenoleukodystrophy. (10.1126/science.284.5422.1985) / Science by KT Min (1999)
  44. Palladino, M. J., Hadley, T. J. & Ganetzky, B. Temperature-sensitive paralytic mutants are enriched for those causing neurodegeneration in Drosophila. Genetics 161, 1197–1208 (2002). (10.1093/genetics/161.3.1197) / Genetics by MJ Palladino (2002)
  45. Fortini, M. E., Skupski, M. P., Boguski, M. S. & Hariharan, I. K. A survey of human disease gene counterparts in the Drosophila genome. J. Cell Biol. 150, F23–F30 (2000). (10.1083/jcb.150.2.F23) / J. Cell Biol. by ME Fortini (2000)
  46. Rubin, G. M. et al. Comparative genomics of the eukaryotes. Science 287, 2204–2215 (2000). (10.1126/science.287.5461.2204) / Science by GM Rubin (2000)
  47. Sonnhammer, E. L. & Durbin, R. Analysis of protein domain families in Caenorhabditis elegans. Genomics 46, 200–216 (1997). (10.1006/geno.1997.4989) / Genomics by EL Sonnhammer (1997)
  48. Fares, H. & Greenwald, I. Regulation of endocytosis by CUP-5, the Caenorhabditis elegans mucolipin-1 homolog. Nature Genet. 28, 64–68 (2001). / Nature Genet. by H Fares (2001)
  49. Hersh, B. M., Hartwieg, E. & Horvitz, H. R. The Caenorhabditis elegans mucolipin-like gene cup-5 is essential for viability and regulates lysosomes in multiple cell types. Proc. Natl Acad. Sci. USA 99, 4355–4360 (2002). (10.1073/pnas.062065399) / Proc. Natl Acad. Sci. USA by BM Hersh (2002)
  50. Izaddoost, S., Nam, S. C., Bhat, M. A., Bellen, H. J. & Choi, K. W. Drosophila Crumbs is a positional cue in photoreceptor adherens junctions and rhabdomeres. Nature 416, 178–183 (2002). (10.1038/nature720) / Nature by S Izaddoost (2002)
  51. Johnson, K., Grawe, F., Grzeschik, N. & Knust, E. Drosophila crumbs is required to inhibit light-induced photoreceptor degeneration. Curr. Biol. 12, 1675–1680 (2002). (10.1016/S0960-9822(02)01180-6) / Curr. Biol. by K Johnson (2002)
  52. Pellikka, M. et al. Crumbs, the Drosophila homologue of human CRB1/RP12, is essential for photoreceptor morphogenesis. Nature 416, 143–149 (2002). (10.1038/nature721) / Nature by M Pellikka (2002)
  53. den Hollander, A. I. et al. Leber congenital amaurosis and retinitis pigmentosa with Coats-like exudative vasculopathy are associated with mutations in the crumbs homologue 1 (CRB1) gene. Am. J. Hum. Genet. 69, 198–203 (2001). (10.1086/321263) / Am. J. Hum. Genet. by AI den Hollander (2001)
  54. Kemp, S. et al. ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Hum. Mutat. 18, 499–515 (2001). (10.1002/humu.1227) / Hum. Mutat. by S Kemp (2001)
  55. Mosser, J. et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361, 726–730 (1993). (10.1038/361726a0) / Nature by J Mosser (1993)
  56. Raeber, A. J., Muramoto, T., Kornberg, T. B. & Prusiner, S. B. Expression and targeting of Syrian hamster prion protein induced by heat shock in transgenic Drosophila melanogaster. Mech. Dev. 51, 317–327 (1995). (10.1016/0925-4773(95)00379-7) / Mech. Dev. by AJ Raeber (1995)
  57. Hurd, D. D. & Saxton, W. M. Kinesin mutations cause motor neuron disease phenotypes by disrupting fast axonal transport in Drosophila. Genetics 144, 1075–1085 (1996). (10.1093/genetics/144.3.1075) / Genetics by DD Hurd (1996)
  58. Elia, A. J. et al. Expression of human FALS SOD in motorneurons of Drosophila. Free Radic. Biol. Med. 26, 1332–1338 (1999). (10.1016/S0891-5849(98)00333-5) / Free Radic. Biol. Med. by AJ Elia (1999)
  59. Oeda, T. et al. Oxidative stress causes abnormal accumulation of familial amyotrophic lateral sclerosis-related mutant SOD1 in transgenic Caenorhabditis elegans. Hum. Mol. Genet. 10, 2013–2023 (2001). (10.1093/hmg/10.19.2013) / Hum. Mol. Genet. by T Oeda (2001)
  60. Selkoe, D. J. Presenilin, Notch, and the genesis and treatment of Alzheimer's disease. Proc. Natl Acad. Sci. USA 98, 11039–11041 (2001). (10.1073/pnas.211352598) / Proc. Natl Acad. Sci. USA by DJ Selkoe (2001)
  61. Daigle, I. & Li, C. apl-1, a Caenorhabditis elegans gene encoding a protein related to the human β-amyloid protein precursor. Proc. Natl Acad. Sci. USA 90, 12045–12049 (1993). (10.1073/pnas.90.24.12045) / Proc. Natl Acad. Sci. USA by I Daigle (1993)
  62. Rosen, D. R., Martin-Morris, L., Luo, L. Q. & White, K. A Drosophila gene encoding a protein resembling the human β-amyloid protein precursor. Proc. Natl Acad. Sci. USA 86, 2478–2482 (1989). (10.1073/pnas.86.7.2478) / Proc. Natl Acad. Sci. USA by DR Rosen (1989)
  63. Luo, L., Tully, T. & White, K. Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for Appl gene. Neuron 9, 595–605 (1992). (10.1016/0896-6273(92)90024-8) / Neuron by L Luo (1992)
  64. Torroja, L., Packard, M., Gorczyca, M., White, K. & Budnik, V. The Drosophila β-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction. J. Neurosci. 19, 7793–7803 (1999). (10.1523/JNEUROSCI.19-18-07793.1999) / J. Neurosci. by L Torroja (1999)
  65. Gunawardena, S. & Goldstein, L. S. Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 32, 389–401 (2001). (10.1016/S0896-6273(01)00496-2) / Neuron by S Gunawardena (2001)
  66. Link, C. D. Expression of human β-amyloid peptide in transgenic Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 92, 9368–9372 (1995). (10.1073/pnas.92.20.9368) / Proc. Natl Acad. Sci. USA by CD Link (1995)
  67. Fay, D. S., Fluet, A., Johnson, C. J. & Link, C. D. In vivo aggregation of β-amyloid peptide variants. J. Neurochem. 71, 1616–1625 (1998). (10.1046/j.1471-4159.1998.71041616.x) / J. Neurochem. by DS Fay (1998)
  68. Tabira, T., Chui, D. H. & Kuroda, S. Significance of intracellular Aβ42 accumulation in Alzheimer's disease. Front. Biosci. 7, a44–a49 (2002). / Front. Biosci. by T Tabira (2002)
  69. Glabe, C. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. J. Mol. Neurosci. 17, 137–145 (2001). (10.1385/JMN:17:2:137) / J. Mol. Neurosci. by C Glabe (2001)
  70. Link, C. D. et al. Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34. Neurobiol. Aging 22, 217–226 (2001). (10.1016/S0197-4580(00)00237-2) / Neurobiol. Aging by CD Link (2001)
  71. Fonte, V. et al. Interaction of intracellular β amyloid peptide with chaperone proteins. Proc. Natl Acad. Sci. USA 99, 9439–9444 (2002). This paper implicates specific heat-shock chaperones in toxicity and metabolism of the intracellular Alzheimer disease-causing Aβ 1-42 fragment in nematodes. (10.1073/pnas.152313999) / Proc. Natl Acad. Sci. USA by V Fonte (2002)
  72. Selkoe, D. J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81, 741–766 (2001). (10.1152/physrev.2001.81.2.741) / Physiol. Rev. by DJ Selkoe (2001)
  73. Levitan, D. & Greenwald, I. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377, 351–354 (1995). (10.1038/377351a0) / Nature by D Levitan (1995)
  74. Li, X. & Greenwald, I. HOP-1, a Caenorhabditis elegans presenilin, appears to be functionally redundant with SEL-12 presenilin and to facilitate LIN-12 and GLP-1 signaling. Proc. Natl Acad. Sci. USA 94, 12204–12209 (1997). (10.1073/pnas.94.22.12204) / Proc. Natl Acad. Sci. USA by X Li (1997)
  75. Arduengo, P. M., Appleberry, O. K., Chuang, P. & L'Hernault, S. W. The presenilin protein family member SPE-4 localizes to an ER/Golgi derived organelle and is required for proper cytoplasmic partitioning during Caenorhabditis elegans spermatogenesis. J. Cell. Sci. 111, 3645–3654 (1998). (10.1242/jcs.111.24.3645) / J. Cell. Sci. by PM Arduengo (1998)
  76. Boulianne, G. L. et al. Cloning and characterization of the Drosophila presenilin homologue. Neuroreport 8, 1025–1029 (1997). (10.1097/00001756-199703030-00041) / Neuroreport by GL Boulianne (1997)
  77. Hong, C. S. & Koo, E. H. Isolation and characterization of Drosophila presenilin homolog. Neuroreport 8, 665–668 (1997). (10.1097/00001756-199702100-00017) / Neuroreport by CS Hong (1997)
  78. Ye, Y., Lukinova, N. & Fortini, M. E. Neurogenic phenotypes and altered Notch processing in Drosophila presenilin mutants. Nature 398, 525–529 (1999). One of the first publications to show the activity of presenilin in Notch processing in the fly. (10.1038/19096) / Nature by Y Ye (1999)
  79. Okochi, M. et al. A loss of function mutant of the presenilin homologue SEL-12 undergoes aberrant endoproteolysis in Caenorhabditis elegans and increases aβ 42 generation in human cells. J. Biol. Chem. 275, 40925–40932 (2000). (10.1074/jbc.M005254200) / J. Biol. Chem. by M Okochi (2000)
  80. Goutte, C., Hepler, W., Mickey, K. M. & Priess, J. R. aph-2 encodes a novel extracellular protein required for GLP-1-mediated signaling. Dev. Suppl. 127, 2481–2492 (2000). / Dev. Suppl. by C Goutte (2000)
  81. Yu, G. et al. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing. Nature 407, 48–54 (2000). (10.1038/35024009) / Nature by G Yu (2000)
  82. Chung, H. M. & Struhl, G. Nicastrin is required for presenilin-mediated transmembrane cleavage in Drosophila. Nature Cell Biol. 3, 1129–1132 (2001). (10.1038/ncb1201-1129) / Nature Cell Biol. by HM Chung (2001)
  83. Lopez-Schier, H. & St Johnston, D. Drosophila nicastrin is essential for the intramembranous cleavage of notch. Dev. Cell 2, 79–89 (2002). (10.1016/S1534-5807(01)00109-5) / Dev. Cell by H Lopez-Schier (2002)
  84. Goutte, C., Tsunozaki, M., Hale, V. A. & Priess, J. R. APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos Proc. Natl Acad. Sci. USA 99, 775–779 (2002). (10.1073/pnas.022523499) / Proc. Natl Acad. Sci. USA by C Goutte (2002)
  85. Francis, R. et al. aph-1 and pen-2 are required for Notch pathway signaling, γ-secretase cleavage of βAPP, and presenilin protein accumulation. Dev. Cell 3, 85–97 (2002). A report of a genetic-interaction screen that identified two C. elegans proteins (with functional human homologues) as new components of the presenilin γ-secretase complex. (10.1016/S1534-5807(02)00189-2) / Dev. Cell by R Francis (2002)
  86. Hubbard, E. J., Wu, G., Kitajewski, J. & Greenwald, I. sel-10, a negative regulator of lin-12 activity in Caenorhabditis elegans, encodes a member of the CDC4 family of proteins. Genes Dev. 11, 3182–3193 (1997). (10.1101/gad.11.23.3182) / Genes Dev. by EJ Hubbard (1997)
  87. Wu, G., Hubbard, E. J., Kitajewski, J. K. & Greenwald, I. Evidence for functional and physical association between Caenorhabditis elegans SEL-10, a Cdc4p-related protein, and SEL-12 presenilin. Proc. Natl Acad. Sci. USA 95, 15787–15791 (1998). (10.1073/pnas.95.26.15787) / Proc. Natl Acad. Sci. USA by G Wu (1998)
  88. Li, J. et al. SEL-10 interacts with presenilin 1, facilitates its ubiquitylation, and alters A-β peptide production. J. Neurochem. 82, 1540–1548 (2002). (10.1046/j.1471-4159.2002.01105.x) / J. Neurochem. by J Li (2002)
  89. Wittenburg, N. et al. Presenilin is required for proper morphology and function of neurons in C. elegans. Nature 406, 306–309 (2000). This study shows a role for presenilin in neuronal morphology and function and specifically implicates presenilin function in thermal memory of C. elegans. (10.1038/35018575) / Nature by N Wittenburg (2000)
  90. Giasson, B. I. & Lee, V. M. Parkin and the molecular pathways of Parkinson's disease. Neuron 31, 885–888 (2001). (10.1016/S0896-6273(01)00439-1) / Neuron by BI Giasson (2001)
  91. Duda, J. E., Lee, V. M. & Trojanowski, J. Q. Neuropathology of synuclein aggregates. J. Neurosci. Res. 61, 121–127 (2000). (10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4) / J. Neurosci. Res. by JE Duda (2000)
  92. Schwartz, L. M., Nambu, J. R. & Wang, Z. Parkinsonism proteolysis and proteasomes. Cell Death Differ. 9, 479–482 (2002). (10.1038/sj.cdd.4401026) / Cell Death Differ. by LM Schwartz (2002)
  93. Nass, R., Miller, D. M. & Blakely, R. D. C. elegans: a novel pharmacogenetic model to study Parkinson's disease. Parkinsonism Relat. Disord. 7, 185–191 (2001). (10.1016/S1353-8020(00)00056-0) / Parkinsonism Relat. Disord. by R Nass (2001)
  94. Nass, R., Hall, D. H., Miller, D. M. & Blakely, R. D. Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 99, 3264–3269 (2002). (10.1073/pnas.042497999) / Proc. Natl Acad. Sci. USA by R Nass (2002)
  95. Feany, M. B. & Bender, W. W. A Drosophila model of Parkinson's disease. Nature 404, 394–398 (2000). The pioneering work establishing a transgenic Drosophila model for Parkinson disease in which human α-synuclein is over-expressed. The fly model features some selective vulnerability for dopaminergic neurons, formation of Lewy-like neuronal inclusions and late-onset neurodegeneration. (10.1038/35006074) / Nature by MB Feany (2000)
  96. Auluck, P. K., Chan, H. Y., Trojanowski, J. Q., Lee, V. M. & Bonini, N. M. Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295, 865–868 (2002). This work shows that transgenic expression of specific HSP70- and HSP40-family members can exert neuroprotective effects against α-synuclein toxicity in flies. (10.1126/science.1067389) / Science by PK Auluck (2002)
  97. Auluck, P. K. & Bonini, N. M. Pharmacological prevention of Parkinson disease in Drosophila. Nature Med. 8, 1185–1186 (2002). This paper reports that geldanamycin treatment, which potentiates HSP70 activity, can be neuroprotective against over-expression of α-synuclein, a good example of how flies can be used to test working hypotheses and potential pharmacological intervention strategies. (10.1038/nm1102-1185) / Nature Med. by PK Auluck (2002)
  98. Pendleton, R. G., Parvez, F., Sayed, M. & Hillman, R. Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster. J. Pharmacol. Exp. Ther. 300, 91–96 (2002). (10.1124/jpet.300.1.91) / J. Pharmacol. Exp. Ther. by RG Pendleton (2002)
  99. Zoghbi, H. Y. & Botas, J. Mouse and fly models of neurodegeneration. Trends Genet. 18, 463–471 (2002). (10.1016/S0168-9525(02)02729-4) / Trends Genet. by HY Zoghbi (2002)
  100. Zoghbi, H. Y. & Orr, H. T. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23, 217–247 (2000). (10.1146/annurev.neuro.23.1.217) / Annu. Rev. Neurosci. by HY Zoghbi (2000)
  101. Warrick, J. M. et al. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93, 939–949 (1998). One of several examples of invertebrate polyglutamine-expansion disease models that parallel human disease progression and cellular characteristics. It is also the basis of a genetic screen described in reference 109. (10.1016/S0092-8674(00)81200-3) / Cell by JM Warrick (1998)
  102. Jackson, G. R. et al. Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21, 633–642 (1998). (10.1016/S0896-6273(00)80573-5) / Neuron by GR Jackson (1998)
  103. Fernandez-Funez, P. et al. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408, 101–106 (2000). A genetic screen that identified proteins with a range of biological functions as modulators of neuronal degeneration caused by expression of an expanded polyglutamine protein. (10.1038/35040584) / Nature by P Fernandez-Funez (2000)
  104. Chan, H. Y., Warrick, J. M., Gray-Board, G. L., Paulson, H. L. & Bonini, N. M. Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila. Hum. Mol. Genet. 9, 2811–2820 (2000). (10.1093/hmg/9.19.2811) / Hum. Mol. Genet. by HY Chan (2000)
  105. Takeyama, K. et al. Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron 35, 855–864 (2002). (10.1016/S0896-6273(02)00875-9) / Neuron by K Takeyama (2002)
  106. Marsh, J. L. et al. Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila. Hum. Mol. Genet. 9, 13–25 (2000). (10.1093/hmg/9.1.13) / Hum. Mol. Genet. by JL Marsh (2000)
  107. Kazemi-Esfarjani, P. & Benzer, S. Genetic suppression of polyglutamine toxicity in Drosophila. Science 287, 1837–1840 (2000). This work describes a genetic screen that showed several loci (including two heat-shock chaperone genes) that enhance or suppress neurodegeneration induced by expression of an expanded polyglutamine fragment. (10.1126/science.287.5459.1837) / Science by P Kazemi-Esfarjani (2000)
  108. Faber, P. W., Alter, J. R., MacDonald, M. E. & Hart, A. C. Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc. Natl Acad. Sci. USA 96, 179–184 (1999). (10.1073/pnas.96.1.179) / Proc. Natl Acad. Sci. USA by PW Faber (1999)
  109. Warrick, J. M. et al. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nature Genet. 23, 425–428 (1999). A demonstration that HSP70 over-expression can suppress neurodegeneration in a fly model of spinocerebellar ataxia (MJD/SCA-3). A similar finding was later reported for a mouse SCA-1 model (reference 114). (10.1038/70532) / Nature Genet. by JM Warrick (1999)
  110. Satyal, S. H. et al. Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 97, 5750–5755 (2000). (10.1073/pnas.100107297) / Proc. Natl Acad. Sci. USA by SH Satyal (2000)
  111. Kazantsev, A. et al. A bivalent Huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila. Nature Genet. 30, 367–376 (2002). (10.1038/ng864) / Nature Genet. by A Kazantsev (2002)
  112. Steffan, J. S. et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413, 739–743 (2001). (10.1038/35099568) / Nature by JS Steffan (2001)
  113. Morley, J. F., Brignull, H. R., Weyers, J. J. & Morimoto, R. I. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 99, 10417–10422 (2002). (10.1073/pnas.152161099) / Proc. Natl Acad. Sci. USA by JF Morley (2002)
  114. Cummings, C. J. et al. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum. Mol. Genet. 10, 1511–1518 (2001). (10.1093/hmg/10.14.1511) / Hum. Mol. Genet. by CJ Cummings (2001)
  115. Ross, C. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 35, 819 (2002). (10.1016/S0896-6273(02)00872-3) / Neuron by C Ross (2002)
  116. Holbert, S. et al. The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proc. Natl Acad. Sci. USA 98, 1811–1816 (2001). (10.1073/pnas.98.4.1811) / Proc. Natl Acad. Sci. USA by S Holbert (2001)
  117. Faber, P. W., Voisine, C., King, D. C., Bates, E. A. & Hart, A. C. Glutamine/proline-rich PQE-1 proteins protect Caenorhabditis elegans neurons from huntingtin polyglutamine neurotoxicity. Proc. Natl Acad. Sci. USA 99, 17131–17136 (2002). A description of a new modifier of polyglutamine-expansion-induced neurodegeneration. (10.1073/pnas.262544899) / Proc. Natl Acad. Sci. USA by PW Faber (2002)
  118. Nambu, J. R., Chen, W., Hu, S. & Crews, S. T. The Drosophila melanogaster similar bHLH-PAS gene encodes a protein related to human hypoxia-inducible factor 1 α and Drosophila single-minded. Gene 172, 249–254 (1996). (10.1016/0378-1119(96)00060-1) / Gene by JR Nambu (1996)
  119. Jiang, H., Guo, R. & Powell-Coffman, J. A. The Caenorhabditis elegans hif-1 gene encodes a bHLH-PAS protein that is required for adaptation to hypoxia. Proc. Natl Acad. Sci. USA 98, 7916–7921 (2001). (10.1073/pnas.141234698) / Proc. Natl Acad. Sci. USA by H Jiang (2001)
  120. Semenza, G. L. HIF-1 and human disease: one highly involved factor. Genes Dev. 14, 1983–1991 (2000). (10.1101/gad.14.16.1983) / Genes Dev. by GL Semenza (2000)
  121. Epstein, A. C. et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43–54 (2001). (10.1016/S0092-8674(01)00507-4) / Cell by AC Epstein (2001)
  122. Lavista-Llanos, S. et al. Control of the hypoxic response in Drosophila melanogaster by the basic helix-loop-helix PAS protein Similar. Mol. Cell. Biol. 22, 6842–6853 (2002). (10.1128/MCB.22.19.6842-6853.2002) / Mol. Cell. Biol. by S Lavista-Llanos (2002)
  123. Wingrove, J. A. & O'Farrell, P. H. Nitric oxide contributes to behavioral, cellular, and developmental responses to low oxygen in Drosophila. Cell 98, 105–114 (1999). (10.1016/S0092-8674(00)80610-8) / Cell by JA Wingrove (1999)
  124. Stamler, J. S. et al. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 276, 2034–2037 (1997). (10.1126/science.276.5321.2034) / Science by JS Stamler (1997)
  125. Xiong, W. C., Okano, H., Patel, N. H., Blendy, J. A. & Montell, C. repo encodes a glial-specific homeo domain protein required in the Drosophila nervous system. Genes Dev. 8, 981–994 (1994). (10.1101/gad.8.8.981) / Genes Dev. by WC Xiong (1994)
  126. Xiong, W. C. & Montell, C. Defective glia induce neuronal apoptosis in the repo visual system of Drosophila. Neuron 14, 581–590 (1995). (10.1016/0896-6273(95)90314-3) / Neuron by WC Xiong (1995)
  127. Nakano, Y. et al. Mutations in the novel membrane protein spinster interfere with programmed cell death and cause neural degeneration in Drosophila melanogaster. Mol. Cell Biol. 21, 3775–3788 (2001). (10.1128/MCB.21.11.3775-3788.2001) / Mol. Cell Biol. by Y Nakano (2001)
  128. Min, K. Drosophila as a model to study human brain degenerative diseases. Parkinsonism Relat. Disord. 7, 165–169 (2001). (10.1016/S1353-8020(00)00053-5) / Parkinsonism Relat. Disord. by K Min (2001)
  129. Fortini, M. E. γ-secretase-mediated proteolysis in cell-surface-receptor signalling. Nature Rev. Mol. Cell. Biol. 3, 673–684 (2002). (10.1038/nrm910) / Nature Rev. Mol. Cell. Biol. by ME Fortini (2002)
  130. Selkoe, D. J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399, A23–A31 (1999). (10.1038/399a023) / Nature by DJ Selkoe (1999)
  131. Struhl, G. & Greenwald, I. Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature 398, 522–525 (1999). (10.1038/19091) / Nature by G Struhl (1999)
  132. DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990–1993 (1997). (10.1126/science.277.5334.1990) / Science by M DiFiglia (1997)
  133. Vonsattel, J. P. et al. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559–577 (1985). (10.1097/00005072-198511000-00003) / J. Neuropathol. Exp. Neurol. by JP Vonsattel (1985)
  134. Parker, J. A. et al. Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death. Proc. Natl Acad. Sci. USA 98, 13318–13323 (2001). (10.1073/pnas.231476398) / Proc. Natl Acad. Sci. USA by JA Parker (2001)
  135. Chan, H. Y., Warrick, J. M., Andriola, I., Merry, D. & Bonini, N. M. Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila. Hum. Mol. Genet. 11, 2895–2904 (2002). (10.1093/hmg/11.23.2895) / Hum. Mol. Genet. by HY Chan (2002)
  136. Schenk, D. amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning. Nature Rev. Neurosci. 3, 824–828 (2002). (10.1038/nrn938) / Nature Rev. Neurosci. by D Schenk (2002)
Dates
Type When
Created 22 years, 6 months ago (Feb. 28, 2003, 8:38 a.m.)
Deposited 3 years, 4 months ago (April 15, 2022, 5:23 p.m.)
Indexed 2 months, 2 weeks ago (June 24, 2025, 11:46 a.m.)
Issued 22 years, 6 months ago (March 1, 2003)
Published 22 years, 6 months ago (March 1, 2003)
Published Print 22 years, 6 months ago (March 1, 2003)
Funders 0

None

@article{Driscoll_2003, title={Dying for a cause: invertebrate genetics takes on human neurodegeneration}, volume={4}, ISSN={1471-0064}, url={http://dx.doi.org/10.1038/nrg1018}, DOI={10.1038/nrg1018}, number={3}, journal={Nature Reviews Genetics}, publisher={Springer Science and Business Media LLC}, author={Driscoll, Monica and Gerstbrein, Beate}, year={2003}, month=mar, pages={181–194} }